BHUVANESWARI NALLAMOTHU: Open Payments
NPI 1063542140 · SUN CITY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,446 in 61 payments from 12 companies in 2025. Trend: 2023 $720 · 2024 $1,356 · 2025 $1,446
Food & beverage: $1,316Education: $130
| Company | Payments | Amount |
|---|---|---|
| Tris Pharma Inc | 9 | $215 |
| Neurocrine BioSciences, Inc. | 8 | $198 |
| Collegium Pharmaceutical, Inc. | 10 | $191 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $167 |
| ABBVIE INC. | 9 | $152 |
| Teva Pharmaceuticals USA, Inc. | 3 | $142 |
| Janssen Pharmaceuticals, Inc | 4 | $103 |
| Lundbeck LLC | 3 | $90 |
| Otsuka America Pharmaceutical, Inc. | 3 | $78 |
| Almatica Pharma LLC | 3 | $78 |
Products named: INGREZZA, Jornay PM, CAPLYTA, VRAYLAR, REXULTI, Onyda XR, INVEGA SUSTENNA, Dyanavel XR.
Industry payments across CA — which companies pay providers there.
